Two studies found that the magnitude of risk reduction by MHT was different between colorectal tumours with higher and with lower expression of ERβ.56, 57 It is possible that the effect of endogenous oestrogens on CRC risk may be modulated by ERβ expression as well. Here, ESR2 is linked to colorectal carcinoma.